Evidence map›Paper›PMID 33987627›Full record

ArticleGlobal medical genetics2021

Granulocytes Acquire Antiapoptosis Activity and Promote Tumor Growth during Tumor Progress.

Han Li, Wenyan Shen, Yanjie Xu, Zien Wang, Linghao Wang, Zequn Ding, Zhiyuan Xie, Yan Zhang

Open access · diamondAbstract read
In one paragraph

Article in Global medical genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Han LiMed-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, People's Republic of China.
Wenyan ShenDepartment of Clinical Laboratory, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, People's Republic of China.
Yanjie XuMed-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, People's Republic of China.
Zien WangMed-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, People's Republic of China.
Linghao WangMed-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, People's Republic of China.
Zequn DingMed-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, People's Republic of China.
Zhiyuan XieMed-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, People's Republic of China.
Yan ZhangMed-X Research Institute & School of Biomedical Engineering, Shanghai Jiaotong University, Shanghai, People's Republic of China.
Shanghai Jiao Tong University · CNRenji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Granulocytes play important roles in cancer, and their apoptotic status is often changed by the influence of tumor environment. However, the changes and the function on granulocyte apoptosis in cancer are unclear. In this study, we used tumor-bearing mouse model and tumor patients to analyzed the apoptosis of granulocytes in different tissues by flow analysis and TUNEL fluorescence staining, and found that the percentage of apoptosis cells in granulocytes was significantly decreased in late-stage tumor-bearing mouse and patients. The in vitro co-culture experiment showed that these antiapoptotic granulocytes could significantly inhibit T cell proliferation, and RNA-seq proved that there was obvious difference on the transcriptome between these cells and control cells, particularly immune-related genes. What is important, adoptive transfer of these antiapoptotic granulocytes promoted tumor progress in mouse model. Conclusively, we found that granulocytes in late-stage tumor could delay the process of apoptosis, inhibit T cell proliferation, and acquire pro-tumor activity, which provides a new therapeutic target for tumor immunity.

Indexed as

apoptosiscancergranulocyte

Identifiers

PMID33987627
PMCPMC8110362
OpenAlexW3139151336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.